Clinical Trials Directory

Trials / Completed

CompletedNCT04191200

Oral Status of Patients Suffering From SCHIZophrenia Followed at Charles Perrens Hospital

Etat BUCCO-dentaire de Patients Atteints de SCHIZophrénie et de Troubles Schizo-affectif Suivis au Centre Hospitalier de Charles Perrens

Status
Completed
Phase
Study type
Observational
Enrollment
51 (actual)
Sponsor
Centre Hospitalier Charles Perrens, Bordeaux · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to describe the oral health status of patients suffering from schizophrenia and schizoaffective disorders in a psychiatric institute in France.

Detailed description

Schizophrenia concerns 21 million people in the world and 600 000 in France according to the World Health Organization. This pathology decreases the patient's quality of life and one patient out of two will try to commit suicide and 10% will die. Oral health is an important factor for general well being. The litterature shows that schizophrenic patients tend to visit less dental surgeries than the general population. Patients will often visit the surgery in emergency and dentist often choses to extract instead of a restorative solution. Thus, schizophrenic subjects are 3,4 more likely to become edentulous compared to the general population. This is a cross-sectional epidemiological study on patients suffering from schizophrenia and and schizoaffective disorders in a psychiatric institution. A dental assessment will be conducted to provide clinical data on oral health. (DMFT, hygiene, mouth dryness, prosthesis) and a survey of their diet, medication, oral quality of life, social security coverage and patients view regarding dental care (Anxiety and Healthcare renunciation). This is an observational study (oral examination and survey), so no treatment will be compared. The oral health status will be evaluated during one single oral examination and survey during the patient's stay at hospital.

Conditions

Timeline

Start date
2019-09-24
Primary completion
2019-12-31
Completion
2019-12-31
First posted
2019-12-09
Last updated
2020-04-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04191200. Inclusion in this directory is not an endorsement.